Madrigal Pharmaceuticals, Inc. - Common Stock (MDGL) stock analysis
MDGL · Madrigal Pharmaceuticals, Inc. - Common Stock
Latest recorded price: USD 423.96
Sector and industry: Healthcare · Biotechnology
Fiscal 2025 figures: free cash flow margin -19.8%. The model flags 2 risk signals for this company (1 high severity).